Importantly, inhibitors of HDAC have been proven or are considered promising chemotherapeutic agents for the treatment of several human diseases including different malignancies and neurodegenerative diseases, and have already been approved for use in humans or are in clinical trials [46]. Here, HDAC9 is linked to neurodegenerative disease.